Editorial: Immunotherapeutic strategies to target cancer stem cells: state of the art in basic research to clinical application

Affiliations

Amirhesam Babajani: Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran
Amirhesam Babajani: Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Marzieh Naseri: Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA, United States
Faezeh Vakhshiteh: Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran
Roya Ghods: Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran
Roya Ghods: Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran
Zahra Madjd: Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran
Zahra Madjd: Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran

Abstract

No abstracts available.

ISSN: 1664-3224 (Online)
Publisher: Frontiers Media S.A.
Country of publisher: Switzerland
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
Website: http://journal.frontiersin.org/journal/immunology